Cameco Corp Files April 2024 6-K with Q1 MD&A

Ticker: CCJ · Form: 6-K · Filed: Apr 30, 2024 · CIK: 1009001

Sentiment: neutral

Topics: regulatory-filing, financial-update, uranium

TL;DR

Cameco dropped its April 6-K, check the Q1 MD&A for uranium biz updates.

AI Summary

Cameco Corporation filed a Form 6-K on April 30, 2024, reporting for the month of April 2024. The filing includes a press release dated April 30, 2024, and management's discussion and analysis for the quarter ended March 31, 2024. Cameco Corporation is a Canadian company involved in miscellaneous metal ores, specifically uranium.

Why It Matters

This filing provides investors with an update on Cameco's financial performance and operational activities for the first quarter of 2024, offering insights into the uranium market.

Risk Assessment

Risk Level: low — This is a routine filing providing financial and operational updates, not indicating any immediate significant risks.

Key Players & Entities

FAQ

What is the primary business of Cameco Corporation?

Cameco Corporation is involved in miscellaneous metal ores, specifically uranium, as indicated by its Standard Industrial Classification code.

What key documents are included in this 6-K filing?

This 6-K filing includes a press release dated April 30, 2024, and management's discussion and analysis for the quarter ended March 31, 2024.

What is the filing date of this Form 6-K?

The filing date of this Form 6-K is April 30, 2024.

Does Cameco Corporation file annual reports under Form 20-F or 40-F?

Cameco Corporation indicates it files annual reports under Form 40-F.

What is the principal executive office address for Cameco Corporation?

The principal executive offices of Cameco Corporation are located at 2121-11th Street West, Saskatoon, Saskatchewan, Canada S7M 1J3.

Filing Stats: 263 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2024-04-30 07:40:57

Filing Documents

Managements discussion and analysis for the quarter ended March 31, 2024

Managements discussion and analysis for the quarter ended March 31, 2024 99.3 Condensed consolidated interim unaudited financial statements for the quarter ended March 31, 2024 99.4 Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 dated April 30, 2024 99.5 Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 dated April 30, 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: April 30, 2024 Cameco Corporation By: /s/ Sean A. Quinn Sean A. Quinn Senior Vice-President, Chief Legal Officer and Corporate Secretary

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing